Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Preface: Conference Proceedings VII Immunonutrition Workshop “Eating for Preventing” [Carovigno, (Italy) May 1-3, 2014]-Second Part-
Volume: 15 Issue: 1
Export Options
About this article
Cite this article as:
Preface: Conference Proceedings VII Immunonutrition Workshop “Eating for Preventing” [Carovigno, (Italy) May 1-3, 2014]-Second Part-, Endocrine, Metabolic & Immune Disorders - Drug Targets 2015; 15 (1) . https://dx.doi.org/10.2174/187153031501150302220411
DOI https://dx.doi.org/10.2174/187153031501150302220411 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
27
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proline-Rich Peptides: Multifunctional Bioactive Molecules as New Potential Therapeutic Drugs
Current Protein & Peptide Science Drug Targeting to the Brain - A Review
Current Nanoscience Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development
Current Topics in Medicinal Chemistry Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Current Pharmaceutical Design Elevated Plasma Level of D-dimer Predicts the High Risk of Early Cognitive Impairment in Type 2 Diabetic Patients as Carotid Artery Plaques become Vulnerable or Get Aggravated
Current Alzheimer Research The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Current Signal Transduction Therapy Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut
Endocrine, Metabolic & Immune Disorders - Drug Targets Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Cystic Fibrosis and the Innate Immune System: Therapeutic Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Glucose in the Pathogenesis of Alzheimers Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?
Central Nervous System Agents in Medicinal Chemistry Neurons vs. Germline: A War of Hormetic Tradeoffs
Current Aging Science Anthocyanins: Chemical Properties and Health Benefits: A Review
Current Nutrition & Food Science Stingless Bee Honey Reduces Anxiety and Improves Memory of the Metabolic Disease-induced Rats
CNS & Neurological Disorders - Drug Targets Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Current Vascular Pharmacology Neurotrophic Factors for Retinal Ganglion Cell Neuropathy - With a Special Reference to Diabetic Neuropathy in the Retina
Current Diabetes Reviews Pharmacokinetics and In Vivo Fate of Drug Loaded Chitosan Nanoparticles<sup>++</sup>
Current Drug Metabolism AMP-Activated Protein Kinase as a Potential Anti-Diabetes Drug Target
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Patients’ Illness Perceptions of Type 2 Diabetes: A Scoping Review
Current Diabetes Reviews Animal Models of Atherosclerosis Progression: Current Concepts
Current Drug Targets - Cardiovascular & Hematological Disorders